Fibroids are the most common benign tumor of the female reproductive tract. Elective services have been suspended due to the COVID-19 pandemic, resulting in a backlog of patients awaiting surgery. When the curve was flattened in the UK, the second phase of the National Health Service's plan to tackle the pandemic was announced with the reintroduction of elective surgery. Guidance emerged on how to prioritize patients based on urgency, taking into account the risk of surgery during the pandemic. 1 Most women needing surgery for fibroids fell into P3 or P4 categories, 2 defined as procedures that could wait for 3 months. The majority were from ethnic minorities due to greater prevalence of fibroids among black women. East London has a diverse patient population: many women are from black, Asian and minority ethnic (BAME) backgrounds. BAME women are over four times more likely to contract, and be adversely affected by, SARS-CoV-2 than their white counterparts. 3 Women whose fibroid surgery was postponed as a result of COVID-19 were identified using electronic patient records (n=22). Verbal consent was obtained for participation in the study at the time of completing the questionnaire, as written consent was not possible/appropriate amid the pandemic. Pre-COVID-19, women completed 'Uterine Fibroid Symptoms and Health-related Quality of Life Questionnaires' (UFS-QOL), a validated tool for assessing patients'